| ALCL | anaplastic large cell lymphoma; |
| ALL | acute lymphocytic leukemia |
| AML | acute myeloid leukemia |
| AMP | amplification |
| APL | acute promyelocytic leukemia |
| ATLL | adult T-cell leukemia lymphoma |
| B-ALL | B-cell acute lymphocytic leukemia |
| B-NHL | B-cell non-Hodgkin lymphoma |
| BRD | bromodomain |
| CLL | chronic lymphocytic leukemia |
| CML | chronic myeloid leukemia |
| CNA | copy number alteration |
| CRD1 | cell cycle regulatory domain 1 |
| CREBBP | CREB-binding protein |
| DLBCL | diffuse large B-cell lymphoma |
| EP300 | E1A binding protein p300 |
| eRNA | enhancer RNA |
| ESC | embryonic stem cell |
| FL | follicular lymphoma |
| GC | germinal center |
| HAT | histone acetyltransferase |
| HATs | histone acetyltransferase |
| HDACs | histone deacetylases |
| HDACis | histone deacetylase inhibitors |
| HL | Hodgkin lymphoma |
| HOMDEL | homozygous deletion |
| HSCs | hematopoietic stem cells |
| HSPCs | hematopoietic stem and progenitor cells |
| IBiD | interferon-binding domain |
| IMiDs | immunomodulatory drugs |
| KIX | kinase-inducible domain of CREB interacting domain |
| LSTFL | limited-stage typical follicular lymphoma |
| MDS | myelodysplastic syndrome |
| MHC class II | major histocompatibility complex class II |
| MM | multiple myeloma |
| NLS | nuclear location signal |
| NKG2D | natural-killer group 2 member D |
| NRID | nuclear receptor interaction domain |
| PHD | plant homeodomain |
| PTCL | peripheral T-cell lymphoma |
| RING | really interesting new gene |
| T-ALL | T-cell acute lymphocytic leukemia |
| TAZ1 | transcriptional-adaptor zinc-finger domain 1 |
| TAZ2 | transcriptional-adaptor zinc-finger domain 2 |
| Tregs | T regulatory cells; ZZ: ZZ-type zinc finger. |